Biosmart Coltd Stock Beta
| 038460 Stock | KRW 5,870 10.00 0.17% |
BioSmart CoLtd fundamentals help investors to digest information that contributes to BioSmart CoLtd's financial success or failures. It also enables traders to predict the movement of BioSmart Stock. The fundamental analysis module provides a way to measure BioSmart CoLtd's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BioSmart CoLtd stock.
BioSmart |
BioSmart CoLtd Company Beta Analysis
BioSmart CoLtd's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current BioSmart CoLtd Beta | 1.02 |
Most of BioSmart CoLtd's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BioSmart CoLtd is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, BioSmart CoLtd has a Beta of 1.0242. This is much higher than that of the Technology Hardware, Storage & Peripherals sector and significantly higher than that of the Information Technology industry. The beta for all Republic of Korea stocks is notably lower than that of the firm.
BioSmart Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BioSmart CoLtd's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of BioSmart CoLtd could also be used in its relative valuation, which is a method of valuing BioSmart CoLtd by comparing valuation metrics of similar companies.BioSmart CoLtd is currently under evaluation in beta category among related companies.
BioSmart CoLtd returns are very sensitive to returns on the market. As the market goes up or down, BioSmart CoLtd is expected to follow.
BioSmart Fundamentals
| Return On Equity | 2.28 | |||
| Return On Asset | 0.0086 | |||
| Profit Margin | (0.03) % | |||
| Operating Margin | 0.01 % | |||
| Current Valuation | 153.4 B | |||
| Shares Outstanding | 19.98 M | |||
| Shares Owned By Insiders | 23.20 % | |||
| Shares Owned By Institutions | 1.07 % | |||
| Price To Earning | 79.80 X | |||
| Price To Sales | 0.33 X | |||
| Revenue | 189.18 B | |||
| Gross Profit | 58.91 B | |||
| EBITDA | 8.09 B | |||
| Net Income | 633.79 M | |||
| Cash And Equivalents | 433.16 M | |||
| Cash Per Share | 966.69 X | |||
| Total Debt | 33.07 B | |||
| Debt To Equity | 0.42 % | |||
| Current Ratio | 1.50 X | |||
| Cash Flow From Operations | 2.33 B | |||
| Number Of Employees | 164 | |||
| Beta | 1.02 | |||
| Market Capitalization | 73.22 B | |||
| Total Asset | 225.85 B | |||
| Retained Earnings | 8.06 B | |||
| Working Capital | 6.46 B | |||
| Current Asset | 22.12 B | |||
| Current Liabilities | 15.66 B | |||
| Z Score | 1.2 | |||
| Annual Yield | 0.02 % | |||
| Net Asset | 225.85 B |
About BioSmart CoLtd Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BioSmart CoLtd's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BioSmart CoLtd using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BioSmart CoLtd based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioSmart CoLtd. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the BioSmart CoLtd information on this page should be used as a complementary analysis to other BioSmart CoLtd's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Complementary Tools for BioSmart Stock analysis
When running BioSmart CoLtd's price analysis, check to measure BioSmart CoLtd's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioSmart CoLtd is operating at the current time. Most of BioSmart CoLtd's value examination focuses on studying past and present price action to predict the probability of BioSmart CoLtd's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioSmart CoLtd's price. Additionally, you may evaluate how the addition of BioSmart CoLtd to your portfolios can decrease your overall portfolio volatility.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Commodity Directory Find actively traded commodities issued by global exchanges |